Ashley McEvoy

Executive Vice President, Worldwide Chair, Johnson & Johnson MedTech

As Executive Vice President and Worldwide Chairman of MedTech at Johnson & Johnson, Ashley McEvoy is transforming the future of healthcare. Under Ashley’s leadership, the $27B organization of almost 60,000 employees, nearly half of the Fortune #36 company’s employee base, drives innovation to save lives and ignite all that’s possible in every human, everywhere.

With a presence in almost every operating room in the world and more than 75 million procedures each year, Johnson & Johnson MedTech is comprised of eleven $1B platforms. The world’s second-largest medical devices business is also leading the industry in developing integrated, digitized solutions to improve outcomes for millions of people around the world.

Ashley is a member of the Johnson & Johnson Executive Committee and leads the MedTech Group Operating Committee. She also serves on the Executive Committee of AdvaMed, the leading global trade association and consortium of companies for the medical devices industry.

Ashley has more than 25 years of experience working at Johnson & Johnson. In her time leading MedTech, she has strengthened the division’s core portfolio, spearheaded the company’s entrance into telehealth, robotics, and digital surgery, and doubled the value of its pipeline to $10 billion in 2020 from 2018. Ashley also led the deployment of $10B in capital across M&A activity in recent years to bolster the portfolio. This targeted business transformation strategy ultimately accelerated performance and led to revenue growth from 1.5% in 2017 to nearly 5% in 2021. It also resulted in market share gains in a majority of MedTech’s platforms, which enjoy #1 or #2 market position today.

Ashley and the global J&J MedTech team were recently recognized by Fast Company as one of the most innovative health companies of 2022. Ashley was recently honored as one of 50 individuals named to Forbes’ inaugural CEO NEXT list and was ranked #1 on the Top 25 Women Leaders in Medical Devices list by The Healthcare Technology Report. She ranked #41 on Fortune’s Most Powerful Women List in 2019 and was named a Woman of Achievement in 2020 by the National Association of Female Executives for her dedication to advancing diversity, equity, and inclusion.  

A Pennsylvania native and graduate of the University of Pennsylvania, Ashley is proud to serve on the Board of Trustees for the Children’s Hospital of Philadelphia (CHOP), where she helps guide the hospital’s mission in delivering safe, high-quality, and family-centered care.  CHOP was ranked #1 on Forbes’ 2022 list of America’s Best Large Employers.

2 blogs from the author


Posted on 14.07.2022

Addressing new expectations for the future of health

The past few years have seen a seismic shift in the entire healthcare landscape. The COVID-19 crisis required a new level of “always-on” and “right now” innovation to enable care to be delivered to the front lines, to all patients, and across geographies. As COVID-19 evolves from an acute crisis to a chronic issue with unpredictable ebbs and flows, the hyper-focused approach to innovation is more important than ever. The world now knows what we can do, even when conditions are less than optimal. Our focus on helping patients by getting the best evidence, tools, and support to clinicians demonstrated the power of collaboration, imagination and dedication. Moving forward, patients and healthcare partners will accept nothing less than that level of commitment to transform the future of health forever.

By Ashley McEvoy Executive Vice President, Worldwide Chair, Johnson & Johnson MedTech


Posted on 30.04.2021

Paving the Path Ahead for MedTech: Innovation, Health Equity and Global Collaboration

More than a year ago, COVID-19 swept across the world, sending us all into lockdown as we battled the pandemic. Today, as we gradually emerge from the impact and experiences of the past year, I am proud and inspired by how resilient we have been and our ability to find new ways of connecting with […]

By Ashley McEvoy Executive Vice President, Worldwide Chair, Johnson & Johnson MedTech